Dynatronics (DYNT) Competitors $0.18 +0.04 (+31.52%) As of 01:34 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends DYNT vs. HSCS, NDRA, AMIX, LGMK, QNRX, AVGR, TIVC, VERO, HSDT, and GCTKShould you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include Heart Test Laboratories (HSCS), ENDRA Life Sciences (NDRA), Autonomix Medical (AMIX), LogicMark (LGMK), Quoin Pharmaceuticals (QNRX), Avinger (AVGR), Tivic Health Systems (TIVC), Venus Concept (VERO), Helius Medical Technologies (HSDT), and GlucoTrack (GCTK). These companies are all part of the "medical equipment" industry. Dynatronics vs. Heart Test Laboratories ENDRA Life Sciences Autonomix Medical LogicMark Quoin Pharmaceuticals Avinger Tivic Health Systems Venus Concept Helius Medical Technologies GlucoTrack Dynatronics (NASDAQ:DYNT) and Heart Test Laboratories (NASDAQ:HSCS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment. Is DYNT or HSCS more profitable? Heart Test Laboratories has a net margin of 0.00% compared to Dynatronics' net margin of -8.88%. Dynatronics' return on equity of -41.41% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Dynatronics-8.88% -41.41% -10.12% Heart Test Laboratories N/A -117.76%-84.09% Does the MarketBeat Community believe in DYNT or HSCS? Dynatronics received 304 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 83.33% of users gave Heart Test Laboratories an outperform vote while only 48.21% of users gave Dynatronics an outperform vote. CompanyUnderperformOutperformDynatronicsOutperform Votes30948.21% Underperform Votes33251.79% Heart Test LaboratoriesOutperform Votes583.33% Underperform Votes116.67% Do analysts rate DYNT or HSCS? Heart Test Laboratories has a consensus price target of $13.50, indicating a potential upside of 286.27%. Given Heart Test Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Heart Test Laboratories is more favorable than Dynatronics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in DYNT or HSCS? 4.2% of Dynatronics shares are held by institutional investors. Comparatively, 17.2% of Heart Test Laboratories shares are held by institutional investors. 8.0% of Dynatronics shares are held by company insiders. Comparatively, 1.8% of Heart Test Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, DYNT or HSCS? Dynatronics has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, Heart Test Laboratories has a beta of 2.9, meaning that its share price is 190% more volatile than the S&P 500. Which has stronger valuation & earnings, DYNT or HSCS? Dynatronics has higher revenue and earnings than Heart Test Laboratories. Heart Test Laboratories is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDynatronics$32.53M0.04-$2.70M-$0.96-0.14Heart Test Laboratories$20K171.26-$6.61M-$7.91-0.44 Does the media prefer DYNT or HSCS? In the previous week, Heart Test Laboratories had 2 more articles in the media than Dynatronics. MarketBeat recorded 2 mentions for Heart Test Laboratories and 0 mentions for Dynatronics. Dynatronics' average media sentiment score of 0.00 equaled Heart Test Laboratories'average media sentiment score. Company Overall Sentiment Dynatronics Neutral Heart Test Laboratories Neutral SummaryHeart Test Laboratories beats Dynatronics on 9 of the 17 factors compared between the two stocks. Get Dynatronics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYNT vs. The Competition Export to ExcelMetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.20M$4.82B$5.37B$9.09BDividend YieldN/A52.58%5.37%4.00%P/E Ratio-0.1425.9786.7617.45Price / Sales0.0458.921,278.6077.80Price / CashN/A50.8936.6032.90Price / Book0.127.834.924.62Net Income-$2.70M$13.87M$117.96M$224.76M7 Day Performance-3.02%3.46%2.19%2.84%1 Month Performance2.47%10.62%3.21%4.81%1 Year Performance-74.83%32.33%26.71%21.17% Dynatronics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYNTDynatronicsN/A$0.18+31.5%N/A-74.8%$1.57M$32.53M-0.19200Analyst ForecastGap UpHigh Trading VolumeHSCSHeart Test Laboratories2.3383 of 5 stars$3.22-5.3%$13.50+319.3%-70.8%$3.16M$14,700.00-0.1510Short Interest ↑Positive NewsNDRAENDRA Life Sciences1.8379 of 5 stars$5.73-4.2%$700,000.00+12,216,304.9%-100.0%$3.08MN/A-0.0120Positive NewsGap DownAMIXAutonomix Medical2.4161 of 5 stars$2.64-8.7%$28.00+960.6%N/A$3.04MN/A-0.161LGMKLogicMark1.0223 of 5 stars$1.44+3.6%N/A-94.2%$2.93M$10.08M-0.0120QNRXQuoin Pharmaceuticals3.2119 of 5 stars$0.57-8.0%$4.00+599.8%-84.8%$2.89MN/A-0.144AVGRAvinger2.4675 of 5 stars$0.80+42.6%$5.00+522.6%-78.3%$2.66M$7.26M-0.0770Analyst ForecastHigh Trading VolumeTIVCTivic Health Systems0.1391 of 5 stars$0.28-10.0%N/A-78.1%$2.63M$957,000.000.0010Positive NewsGap UpVEROVenus Concept2.6363 of 5 stars$0.36-6.7%N/A-72.9%$2.61M$67.20M-0.04410News CoveragePositive NewsGap UpHSDTHelius Medical Technologies1.665 of 5 stars$0.68+4.8%$24.00+3,429.4%-89.5%$2.54M$502,000.00-0.1130News CoveragePositive NewsHigh Trading VolumeGCTKGlucoTrack0.4284 of 5 stars$0.15+27.9%N/A-92.6%$2.40MN/A-0.055Gap UpHigh Trading Volume Related Companies and Tools Related Companies Heart Test Laboratories Competitors ENDRA Life Sciences Competitors Autonomix Medical Competitors LogicMark Competitors Quoin Pharmaceuticals Competitors Avinger Competitors Tivic Health Systems Competitors Venus Concept Competitors Helius Medical Technologies Competitors GlucoTrack Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DYNT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynatronics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynatronics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
